Because rest is not enough

Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.

Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.

REST IS NOT ENOUGH.

More About What We Do

“Historically, we have minimized and ignored concussion injuries. Treatment is focused on the symptoms and not a cure.  Back when I was playing sports, “getting your bell rung” and going back into the game was a rite of passage.  Yet, if I hurt my knee or ankle, I’d be carried off the field and sent to get an MRI.  Today, we know that there can be significant and long-lasting and significant damage after a single concussion. Millions of people continue to suffer for weeks, months, years and even lifetimes as a result of a lack of effective treatments.  It is clear that the primary therapy to date is inadequate to address the needs of millions that continue to suffer from daily after sustaining a concussion.  Rest is not enough.“

Dr. Michael Wyand
CEO, Oxeia Biopharmaceuticals